Lastly, CYP2E1 seems to favor the progression of obesity-associated fatty liver to NASH, which is characterized by necroinflammation and fibrosis [2,3,37,38]. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatohepatitis.